Abstract

Aim: to analyze the data obtained from using of intraocular lenses — the hydrophobic IOL Citrin and a hydrophilic IOL Aquamarine, produced by Russian company — NanOptic. Materials and methods. A total of 56 IOLs, produced by NanOptic (38 hydrophobic IOLs Citrine and 18 hydrophilic IOLs Aquamarine) were implanted. The observation period was from 3 to 12 months. The indication for phacoemulsification was age cataract. The age of the patients was 54–85. Patients before the operation were conducted basic studies. The mean uncorrected visual acuity before the operation was (UCVA) 0.121 ± 0.120 (0.001–0.3), and the mean corrected visual acuity was (BCVA) 0.187 ± 0.140 (0.001–0.6). All patients underwent standard phacoemulsification. Results. The early postoperative period was without any complications. In the postoperative period the mean UCVA in patients with “Citrine” and “Aquamarine” was 0.90 ± 0.10 (0.7–1.0) and 0.96 ± 0.07 (0.8–1.0) accordingly, and the mean BCVA was 0.94 ± 0.07 (0.8–1.0) and 0.99 ± 0.02 (0.9–1.0) accordingly. In all cases, the refraction obtained was consistent with the prediction. The error in IOL calculation was minimal and permissible. There weren’t any case of secondary cataract in patients with hydrophobic IOLs, and 3 cases of lens posterior capsule fibrosis of 1 degree in patients with hydrophilic IOLs in 3–12 months observation. The position of IOL in capsule bag was stable. Conclusions. The results of implantation of new Russian-made IOLs on the given parameters appeared to be satisfactory, that allows to recommend them for implantation in cataract surgery.

Highlights

  • Aim: to analyze the data obtained from using of intraocular lenses — the hydrophobic IOL Citrin and a hydrophilic IOL Aquamarine, produced by Russian company — NanOptic

  • The refraction obtained was consistent with the prediction

  • The results of implantation of new Russian-made IOLs on the given parameters appeared to be satisfactory, that allows to recommend them for implantation in cataract surgery

Read more

Summary

Пациенты и методы

Всего за период с июня 2017 по июнь 2018 года было прооперировано 56 пациентов (56 глаз) с катарактой, которым было имплантировано 38 гидрофобных ИОЛ. Пациентам были проведены стандартные исследо‐ вания: определение максимальной некорригированной остроты зрения (UCVA) и максимальной корригиро‐ ванной остроты зрения (BCVA), авторефрактометрия (Huvitz), биометрия (IOL-Master 700 Carl Zaiss и А-скан OcuSound, Inc), биомикроскопия, измерение ВГД, ос‐ мотр глазного дна в условиях мидриаза. Перед опера‐ цией средняя UCVA составила 0,121 ± 0,120 (0,001–0,3), BCVA — 0,187 ± 0,140 (0,001–0,6). Для имплантации ИОЛ применяли инжекторы Comport C (RET Inc, Корея) 2,4 мм. В послеоперационном периоде оценивали соот‐ ветствие заданной и полученной рефракции, уровень сложности имплантации (прохождение через инжек‐ тор 2,4 мм, скорость раскрытия ИОЛ в глазу, центрация в капсульном мешке), длительность послеоперационной реабилитации, стабильность рефракции, частоту раз‐ вития вторичной катаракты в период наблюдения после проведения стандартной факоэмульсификации у паци‐ ентов с катарактой

Результаты и обсуждение
Сведения об авторах
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.